Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00276237 · ClinicalTrials.gov registry record
Outcomes Following Pulmonary Valve Replacement in Adults
A clinical trial of Heart Disease, Congenital and Pulmonary Valve Replacement, sponsored by Emory University.
- Completed
- Registry status
- 300
- Enrollment target
- 2
- Study locations
NCT00276237 is a study of Heart Disease, Congenital and Pulmonary Valve Replacement that has completed, run by Emory University. The registered enrollment target is 300 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT00276237, a study of Heart Disease, Congenital and Pulmonary Valve Replacement, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
- 2
- Study locations
Study Summary
One of the most common residual lesions in adult survivors of pediatric cardiac surgery is pulmonary valve disease, particularly regurgitation. Multiple studies have demonstrated that placement of a pulmonary valve in such patients, results in improved ventricular function and resolution of symptoms. However, the optimal prosthetic valve for use in the pulmonary position has not been defined. There are essentially three alternatives available: the stented bioprosthetic valve, stentless bioprosthetic "tube" grafts used to replace the entire right ventricular outflow tract and mechanical valves. All three of these valve options have been used in adults with congenital heart disease at Emory Healthcare and at Children's Healthcare of Atlanta at Egleston. The goal of this study is to evaluate and compare the indications and short and mid-term outcomes for these alternative therapies.
Conditions Studied
Study Locations (2)
Georgia
- Children's Healthcare of Atlanta - Atlanta
- Emory Healthcare System - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2005-07 |
| Est. Completion | 2005-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00276237
The ClinicalTrials.gov registry entry for NCT00276237 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Heart Disease, Congenital appearing as the primary indexed condition, and to 0 interventions.
NCT00276237 reports 2 study locations spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT00276237 about?
NCT00276237 is a clinical study titled "Outcomes Following Pulmonary Valve Replacement in Adults". One of the most common residual lesions in adult survivors of pediatric cardiac surgery is pulmonary valve disease, particularly regurgitation. Multiple studies have demonstrated that placement of a pulmonary valve in such patients, results in improved ventricular function and resolution of symptom...
What is the current status of trial NCT00276237?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2005-07. Estimated completion is 2005-11.
What conditions does trial NCT00276237 study?
This clinical trial studies the following conditions: Heart Disease, Congenital, Pulmonary Valve Replacement.
Who is sponsoring clinical trial NCT00276237?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00276237 being conducted?
This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Disease, Congenital
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.